-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GSK-4406371A in Rubella (German Measles)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.GSK-4406371A in Rubella (German Measles)Drug Details:GSK-4406371A is under development for the prevention of measles, mumps, rubella, and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Measles + Rubella) Vaccine in Rubella (German Measles)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Measles + Rubella) Vaccine in Rubella (German Measles) Drug Details: The vaccine candidate is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Measles + Rubella) Vaccine in Rubella (German Measles)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Measles + Rubella) Vaccine in Rubella (German Measles) Drug Details: Vaccine candidate is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Measles [Strain Edmonstons-Zagreb] + Rubella [Strain Ra-27]) Vaccine in Rubella (German Measles)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Measles [Strain Edmonstons-Zagreb] + Rubella [Strain Ra-27]) Vaccine in Rubella (German Measles)Drug Details:Vaccine candidate is under...
-
Product Insights
New![]()
Langerlo Biomass Power Plant Unit 2
Langerlo Biomass Power Plant Unit 2 is a biopower project located in Limburg, Belgium. The project is owned by German Pellets GmbH. The project came online in 1976. Empower your strategies with our Langerlo Biomass Power Plant Unit 2 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the...
-
Product Insights
New![]()
Langerlo Biomass Power Plant Unit 1
Langerlo Biomass Power Plant Unit 1 is a biopower project located in Limburg, Belgium. The project is owned by German Pellets GmbH. The project came online in 1975. Empower your strategies with our Langerlo Biomass Power Plant Unit 1 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the...
-
Sector Analysis
New![]()
Turkey Destination Tourism Trends Insight by Type, Source Markets, Foreign Direct Investment and Future Opportunities, 2023 Update
Turkey Destination Tourism Insight Report Overview The total number of inbound tourists in Turkey is expected to exceed 2019 levels in 2023 reaching 48.5 million with a projected CAGR of more than 7% between 2022 and 2027. Turkey is a country that is geographically distinct because it is divided between Asia and Europe. Even though most of its tourism still centers on historical monuments and beach resorts, the country is growing as a popular destination for medical treatment, cosmetic procedures,...
-
Sector Analysis
New![]()
Front-of-Shirt Sponsorship in the Top 10 European Soccer Leagues, 2023-24 – Analyzing Biggest Deals, Sports League, Brands and Case Studies
Top 10 European Soccer Leagues Front-of-Shirt Deals Report Overview The industry spends across the top ten European soccer leagues for the 2023-2024 season is worth $446.84 million. The travel & tourism industry remains the biggest market spenders. Financial services and the gambling industries make up the rest of the top three biggest sector spenders this season. The ‘Front-of-Shirt Sponsorship in the Top 10 European Soccer Leagues, 2023-2024 report illustrates the key developments in topflight soccer offering bespoke insight as to...
-
Sector Analysis
New![]()
Germany Thermal Power Market Analysis by Size, Installed Capacity, Power Generation, Regulations, Key Players and Forecast to 2035
Germany Thermal Power Market Report Overview The cumulative capacity for thermal power in Germany was 72.8 GW in 2022. It is expected to decline at a CAGR of more than (2) % during 2022-2035. The German thermal power market research report offers comprehensive information and an understanding of the thermal power market in Germany. The report discusses the thermal power market in the country and provides forecasts up to 2035. Germany Thermal Power Market Outlook, 2022-2035 (GW) Buy the Full...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – NK Cell-AML in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.NK Cell-AML in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drug Details:Gene modified cell therapy is...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.